Equity Research Coverage Reports

Sipa Resources Limited (ASX: SRI) - Uganda/ WA - Junior Explorer - Gold/ Copper
Monday, September 12, 2016
Sipa’s exploration activities are focussed on two areas – the Kitgum Pader Project in northern Uganda, and the recently acquired Paterson North Project in Western Australia. The Company was first mover at Kitgum Pader, and since commencing exploration in 2012 has made two key greenfields discoveries
Download Report
Orion Gold NL (ASX: ORN) - Counter Cyclical Strategy - Gold - South Africa/ WA
Friday, September 9, 2016
We have a midpoint valuation of $30.7m, or $0.053/share for Orion - this is based on a share structure diluted for shares to be issued for the acquisition of Prieska
Download Report
US Masters Residential Property Fund (ASX: URF) - 1H16 Results - Operating Loss driven by Interest & Foreign Currency
Monday, September 5, 2016
Revenue continued to improve in the 1H16, up 50% on the pcp, as a result of the increased number of properties leased out over the period. As the Fund continues to increase the number of properties available for rent, revenue will continue to improve. While revenue was up, the Fund reported a $12.2m operating loss.
Download Report
Codan Limited - (ASX: CDA) - FY16 Results - Margin Improvements Deliver 66% Increase In Underlying NPAT
Monday, August 29, 2016
We have revised our target price for CDA up to $1.56 from $1.04 per share. This represents a 24.8% premium to the share price at 25 August 2016. We retain the 12.6x multiple to FY17 EPS to determine the target price.
Download Report
Race Oncology Ltd ( ASX: RAC) - Drug Development - Treatment of Acute Myeloid Leukaemia
Monday, July 25, 2016
We say ‘re-development’ because Bisantrene, a small molecule anthracene derivative, gained its first marketing approval 26 years ago. The drug originated back in the 1980s in a successful development programme overseen by the major US pharma company Lederle.
Download Report